Extracellular vesicles (EVs) are membranous particles released from nearly all cell types into all bodily fluids evaluated to date ? including serum and plasma. Depending on tissue of origin, health state and organism age, they carry a variety of complex cargo consisting of nucleic acids (5,000 microRNA documented to date), proteins (93,000 documented to date including cytokines) and metabolites. Due to their coordinate regulation of tissue homeostasis and biological processes through intercellular trafficking of microRNA and protein cargo, EVs are particularly attractive for this project because they can potentially serve as DIRECT biomarkers of aging, namely indicators AND mediators of the aging process. The goal of this project is to establish EVs with their microRNA and protein constituents as biomarkers of healthspan and lifespan and to inform biological mechanisms promoting healthspan and lifespan. We focus particularly on three of the hallmarks of aging, epigenetic alterations, cellular senescence and altered inter-cellular communication. Increasing evidence suggests that EVs secreted from senescent cells have unique characteristics and contribute to modulating the phenotype of recipient cells; thus, they have been newly deemed novel senescence associated molecular pattern (SASPs). We hypothesize expression of different amounts and different compositions of EVs are associated with different lifespan and healthspan of humans, and with different senescence states in murine models. In collaboration with Meso Scale Diagnostics, LLC (MSD), a premier developer of highly reliable and highly sensitive biomarker assays, we will develop new biomarkers of EVs informing aging mechanisms and test their function in vitro. These biomarkers will be qualified in the context of aging in our existing extensive human sample sets: individuals (n=3056) from multiple longitudinal cohort studies (EPESE aged >71 years; PALS aged 20-100 years) and NIH-funded controlled trials of geroprotective interventions (STRRIDE exercise aged 18-70 years; and CALERIE caloric restriction aged 22-45 years). Complementing this new biomarker development work, we will validate and qualify: the new S-PLEX high sensitivity (femtomole level detection) assays by MSD for soluble cytokines and circulating microRNAs we have identified as associated with healthspan and lifespan in elders. Taken together, we believe our broad expertise in biomarkers and aging, our interdisciplinary team and our partnership with a company with the capability to commercialize assays provide a unique project responsive to RFA-AG-18-018 for ?Development of valid reliable markers of aging-related biologic mechanisms for human studies?.

Public Health Relevance

In contrast to the existing biological paradigm of an abundance of freely circulating molecules in the bloodstream, it is becoming increasingly clear that many different molecules are shuttled together as cargo protected within membrane bound vesicles. These vesicles are secreted from all cells in the body and have the ability to transmit signals and have biological effects on other parts of the body. Using large numbers of already collected precious human specimens, this project characterizes the types and role of these vesicles in aging and develops new blood biomarker tests for these vesicles to better understand mechanisms of aging and ways to extend healthspan.

National Institute of Health (NIH)
National Institute on Aging (NIA)
High Priority, Short Term Project Award (R56)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1)
Program Officer
Rossi, Winifred K
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code